Evidence map›Paper›PMID 41976327›Full record

ArticleCancers2026

Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights.

Yuhki Yokoyama, Yoshihiro Morimoto, Hiroyuki Yamamoto, Shihori Kouda, Shiho Kawanami, Ruijia Yang, Yingjue Zhang, Manami Tsujimoto, Nanami Nagata, Yuki Shimomura and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yuhki YokoyamaDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Yoshihiro MorimotoDepartment of Gastroenterological Surgery, Osaka General Medical Center, 3-1-56 Bandaihigashi, Osaka 558-8558, Osaka, Japan.ORCID 0000-0003-2687-9933
Hiroyuki YamamotoDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Shihori KoudaDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Shiho KawanamiDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Ruijia YangDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Yingjue ZhangDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Manami TsujimotoDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Nanami NagataDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Yuki ShimomuraNanobeyond Inc., 7-7-15 Saito-Asagi, Ibaraki 567-0085, Osaka, Japan.
Kana NishidaNanobeyond Inc., 7-7-15 Saito-Asagi, Ibaraki 567-0085, Osaka, Japan.
Tsuyoshi HataDepartment of Surgery, Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, 2-2, Yamadaoka, Suita 565-0871, Osaka, Japan.
Akira InoueDepartment of Gastroenterological Surgery, Ikeda City Hospital, 3-1-18 Jyonan, Ikeda 563-8510, Osaka, Japan.ORCID 0000-0002-5000-9084
Satoshi ShibataDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Hirofumi YamamotoDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, The University of Osaka, 1-7, Yamadaoka, Suita 565-0871, Osaka, Japan.
Masaki MoriGraduate School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.

Funding

JSPS KAKENHI Grant 15H04920JSPS KAKENHI Grant 24H00642METI Monozukuri R&D Support Grant Program for SMEs JPJ005698
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer stem cellsmiR-4711-5ppancreatic cancerprimatesafety evaluation

Identifiers

PMID41976327
PMCPMC13071966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.